Literature DB >> 7641812

Induction of cyclin B and H1 kinase activity in apoptotic PC12 cells.

C Y Gao1, P S Zelenka.   

Abstract

The present study examines whether cyclin B may be involved in apoptosis of neuronally differentiated PC12 cells following withdrawal of NGF. Cyclin B mRNA increased approximately 10-fold 4 days after NGF withdrawal, as indicated by competitive RT/PCR. Sequencing of the PCR product confirmed that it was derived from cyclin B mRNA. Cyclin B protein increased in parallel with cyclin B mRNA, as shown by immunoblotting. Immunoprecipitation with anti-cyclin B antibody demonstrated that cyclin B was associated with H1K activity, which reached a maximum 5 days after NGF withdrawal. When proteins immunoprecipitated with anti-cyclin B antibody were immunoblotted with anti-PSTAIR antibody, a protein with apparent molecular weight of 34 kDa was detected. This protein was identified as p34cdc2 on the basis of immunoreactivity with antibody against the C-terminal portion of mouse p34cdc2. Since cyclin B/p34cdc2 complexes are known to catalyze chromosomal condensation and nuclear envelope breakdown during mitosis, these results suggest that cyclin B/p34cdc2 may play some role in the nuclear changes accompanying apoptosis of PC12 cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7641812     DOI: 10.1006/excr.1995.1271

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  19 in total

1.  Apoptosis: A Current Molecular Analysis.

Authors:  Dean G Tang; Arthur T Porter
Journal:  Pathol Oncol Res       Date:  1996       Impact factor: 3.201

2.  Energy metabolism and protein phosphorylation during apoptosis: a phosphorylation study of tau and high-molecular-weight tau in differentiated PC12 cells.

Authors:  P K Davis; G V Johnson
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

3.  Cyclin-dependent kinases and P53 pathways are activated independently and mediate Bax activation in neurons after DNA damage.

Authors:  E J Morris; E Keramaris; H J Rideout; R S Slack; N J Dyson; L Stefanis; D S Park
Journal:  J Neurosci       Date:  2001-07-15       Impact factor: 6.167

Review 4.  Histopathological evaluation of apoptosis in cancer.

Authors:  Y Soini; P Pääkkö; V P Lehto
Journal:  Am J Pathol       Date:  1998-10       Impact factor: 4.307

5.  Expression of cell cycle-related genes during neuronal apoptosis: is there a distinct pattern?

Authors:  A Shirvan; I Ziv; R Zilkha-Falb; T Machlyn; A Barzilai; E Melamed
Journal:  Neurochem Res       Date:  1998-05       Impact factor: 3.996

6.  G1/S cell cycle blockers and inhibitors of cyclin-dependent kinases suppress camptothecin-induced neuronal apoptosis.

Authors:  D S Park; E J Morris; L A Greene; H M Geller
Journal:  J Neurosci       Date:  1997-02-15       Impact factor: 6.167

7.  Involvement of retinoblastoma family members and E2F/DP complexes in the death of neurons evoked by DNA damage.

Authors:  D S Park; E J Morris; R Bremner; E Keramaris; J Padmanabhan; M Rosenbaum; M L Shelanski; H M Geller; L A Greene
Journal:  J Neurosci       Date:  2000-05-01       Impact factor: 6.167

Review 8.  Cell cycle reactivation in mature neurons: a link with brain plasticity, neuronal injury and neurodegenerative diseases?

Authors:  Karina Hernández-Ortega; Ricardo Quiroz-Baez; Clorinda Arias
Journal:  Neurosci Bull       Date:  2011-06       Impact factor: 5.203

Review 9.  Kinase cascades regulating entry into apoptosis.

Authors:  P Anderson
Journal:  Microbiol Mol Biol Rev       Date:  1997-03       Impact factor: 11.056

10.  Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson's disease.

Authors:  Patrice D Smith; Stephen J Crocker; Vernice Jackson-Lewis; Kelly L Jordan-Sciutto; Shawn Hayley; Matthew P Mount; Michael J O'Hare; Steven Callaghan; Ruth S Slack; Serge Przedborski; Hymie Anisman; David S Park
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-31       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.